Recent Finacing
Recent Raise
GluSense develops Glyde, a miniature long-term injectable subcutaneous continuous glucose sensor that wirelessly transmits measurements to a wearable, intended for one-year use and clinical validation in Type 1 Diabetes.
Focus Areas
Recent Investors
Funding round
Investor